We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Diabetes
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
This study aims to evaluate the diabetes risk assessment process in dental settings. One of the reasons to risk assess for a medical condition (type 2 diabetes) in dental settings is that many people see their dentist regularly when they feel healthy. But many people only see their GP when they have a health problem or feel unwell. This may allow dental teams to pick up problems early. Furthermore, patients with periodontitis (severe gum disease) are more likely to have other chronic inflammatory diseases, including type 2 diabetes. So, this may be another reason why dental teams could be used to identify those at risk of diabetes. Although for this study, all dental patients, regardless of their gum health status, will be welcome to participate. If risk-assessing patients for type 2 diabetes in a dental setting is practical and both patients and dental teams think it is a good idea, then it may lead to earlier diagnosis for patients. This, in turn, may mean they can access care sooner. Early identification benefits patients' health and well-being and may also save the NHS money. If this research shows that knowing the patients' gum health status can provide an additional benefit in the screening process, members of the dental team may be best placed to provide this type of risk assessment.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Patients aged <40 years or >=80 years2. Diagnosis of type 1 or type 2 diabetes3. Diagnosis of sickle cell or sickle cell trait4. Unable to provide informed consent5. Pregnant6. They have knowingly been tested for diabetes in the past 12 months
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Zehra
Yonel
+44 (0)1214665128
z.yonel@bham.ac.uk
The study is sponsored by University of Birmingham and funded by Haleon Plc.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 63817
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
